Clinical study of acupuncture on treating chemotherapy induced peripheral neuropathy
- Conditions
- chemotherapy induced peripheral neuropathy
- Registration Number
- ITMCTR2100004778
- Lead Sponsor
- Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1.Patients with tumors diagnosed by pathological cytology or histology;
2.There were numbness, hypoesthesia, pain and paresthesia in extremities after chemotherapy with platinum or taxanes. Some patients have muscle spasm, muscle weakness, myalgia, and even paralysis;
3.Peripheral neuropathy of grade 1 or above according to NCI adverse reaction evaluation criteria within 7 days to 2 years after stopping chemotherapy;
4.The main TCM syndrome is qi deficiency and blood stasis;
5.The Eastern Oncology Cooperative Group (EOCG) score is 0-3;
6.The expected survival time is more than 3 months.
1.Patients receiving other medications that may cause neurotoxicity;
2.Receive any drugs that are suspected to be effective, such as tricyclic antidepressants or anticonvulsants;
3.Patients with severe heart, liver, kidney, immune and hematopoietic system diseases;
4.Pregnant women and lactating women;
5.Patients are fear of acupuncture, allergy to stainless steel needle and other reasons can not accept acupuncture treatment.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Classification of NCI-CTCAE peripheral neuropathy;
- Secondary Outcome Measures
Name Time Method Digital pain grading score;Score of EORTC QLQ-CIPN20 Scale;syndrome of qi deficiency and blood stasis;